Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances controlled‑substances bill adding a fentanyl derivative; members debate kratom implications
Summary
HB 2765, which updates the Uniform Controlled Substances Act and moves certain fentanyl derivatives to Schedule I, advanced out of committee after debate over whether to target synthetic derivatives (such as 7‑hydroxymitragynine/’708’ products) while leaving raw kratom unscheduled; law‑enforcement support and veteran‑care concerns featured prominently.
The committee considered House Bill 27‑65 to revise the Uniform Controlled Substances Act, add or remove substances from Schedules 1–4, and update the state’s definition of fentanyl‑related controlled substances to reflect recent federal action.
Carly (committee staff) and members walked through technical changes and how the bill would place some fentanyl derivatives on Schedule I while allowing medically used fentanyl on other schedules to…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
